These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 661869)

  • 21. In vitro assay for prekallikrein activator (PKA).
    Lundblad JL
    Dev Biol Stand; 1979; 44():107-14. PubMed ID: 317466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zinc-dependent activation of the plasma kinin-forming cascade by aggregated beta amyloid protein.
    Shibayama Y; Joseph K; Nakazawa Y; Ghebreihiwet B; Peerschke EI; Kaplan AP
    Clin Immunol; 1999 Jan; 90(1):89-99. PubMed ID: 9884356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema.
    Schapira M; Silver LD; Scott CF; Schmaier AH; Prograis LJ; Curd JG; Colman RW
    N Engl J Med; 1983 May; 308(18):1050-3. PubMed ID: 6601240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The assay of prekallikrein activator in human blood products.
    Snape TJ; Griffith D; Vallet L; Wesley ED
    Dev Biol Stand; 1979; 44():115-20. PubMed ID: 317467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural and functional characterization of factor XII.
    Tans G; Rosing J
    Semin Thromb Hemost; 1987 Jan; 13(1):1-14. PubMed ID: 3551074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The plasma bradykinin-forming pathways and its interrelationships with complement.
    Kaplan AP; Ghebrehiwet B
    Mol Immunol; 2010 Aug; 47(13):2161-9. PubMed ID: 20580091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
    Weiss AS; Gallin JI; Kaplan AP
    J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation.
    Kaplan AP
    Fed Proc; 1983 Nov; 42(14):3123-7. PubMed ID: 6556144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors XI and XII and prekallikrein in sick and healthy premature infants.
    Andrew M; Bhogal M; Karpatkin M
    N Engl J Med; 1981 Nov; 305(19):1130-3. PubMed ID: 6912944
    [No Abstract]   [Full Text] [Related]  

  • 30. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
    Revak SD; Cochrane CG; Griffin JH
    J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma prekallikrein activity in patients with total hip arthroplasty.
    Hoffmann JJ; Kortmann JH
    Thromb Haemost; 1987 Dec; 58(4):1040-2. PubMed ID: 3445224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-infectious and non-immunologic complications of blood transfusion.
    Snyder EL
    Conn Med; 1979 Apr; 43(4):206-11. PubMed ID: 436416
    [No Abstract]   [Full Text] [Related]  

  • 33. Plasma levels of bradykinin are suppressed in factor XII-deficient mice.
    Iwaki T; Castellino FJ
    Thromb Haemost; 2006 Jun; 95(6):1003-10. PubMed ID: 16732380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein "like" activity in human plasma.
    Gallimore MJ; Friberger P
    Thromb Res; 1982 Feb; 25(3):293-8. PubMed ID: 6917564
    [No Abstract]   [Full Text] [Related]  

  • 35. Generation of active fragments from human zymogens in the bradykinin-generating cascade by extracellular proteases from Vibrio vulnificus and V. parahaemolyticus.
    Miyoshi S; Watanabe H; Kawase T; Yamada H; Shinoda S
    Toxicon; 2004 Dec; 44(8):887-93. PubMed ID: 15530971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies on plasma prekallikrein assay method with chromogenic substrates (S-2302)].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1983 Feb; 31(2):219-22. PubMed ID: 6190027
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of heparin on the activation of factor XII and the contact system in plasma.
    Pixley RA; Cassello A; De La Cadena RA; Kaufman N; Colman RW
    Thromb Haemost; 1991 Nov; 66(5):540-7. PubMed ID: 1725067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of the contact system in ascites from patients with gastrointestinal cancer.
    Buø L; Karlsrud TS; Johansen HT; Aasen AO
    Agents Actions Suppl; 1992; 38 ( Pt 2)():237-48. PubMed ID: 1281373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SPPS and hypotension.
    Schiff P
    N Z Med J; 1992 May; 105(933):181. PubMed ID: 1589171
    [No Abstract]   [Full Text] [Related]  

  • 40. Prekallikrein activator levels and side effects with human albumin preparations.
    Lüben G; Quast U; Geiger H
    Dev Biol Stand; 1980; 48():123-7. PubMed ID: 6974110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.